Archives
-
High Viscosity, YAP, and P-gp Chemoresistance
2026-09-23
The reference study identifies extracellular fluid viscosity as a mechanical regulator of doxorubicin resistance, linking cytoskeletal remodeling and water influx to membrane tension, TRPV4–Ca2+ signaling, YAP activation, and P-gp upregulation. Its findings expand drug resistance research beyond biochemical cues and suggest that tumor-fluid mechanics should be considered when interpreting transporter-mediated drug disposition and cancer chemoresistance studies.
-
Cpf1/Cas12a: Structure, Function, and Editing Logic
2026-09-22
Safari and colleagues synthesized structural, biochemical, and engineering evidence showing why Cpf1, now commonly called Cas12a, is a distinct alternative to Cas9. The review highlights T-rich PAM recognition, tracrRNA-independent guide processing, staggered DNA cleavage, and engineered variants as design features that shape genome-editing workflows.
-
Praeruptorin A: From Mechanism to Translation
2026-09-22
Praeruptorin A is an angular pyranocoumarin compound with a distinctive translational profile spanning DMT1-linked ferroptosis, inflammatory signaling, intestinal barrier repair, doxorubicin-associated myocardial injury, and hepatocellular carcinoma cell migration. This perspective connects those mechanisms to practical study design while distinguishing promising preclinical evidence from clinically validated conclusions.
-
WDR36, Glycolysis, and Trophectoderm Fate
2026-09-21
This study identifies WDR36 as a regulator of human blastoid formation and trophectoderm commitment through glycolytic metabolism. By combining embryonic perturbation, transcriptomics, targeted metabolomics, and protein-interaction analysis, the work connects WDR36 with LDHA-dependent glucose metabolism during early lineage specification.
-
Gut Microbiota, PCN, and Sepsis Liver Injury
2026-09-21
A 2026 study identifies the gut microbiota as a necessary mediator of Pregnenolone-16α-carbonitrile protection against sepsis-induced liver injury in mice. By combining microbiota depletion, fecal transplantation, sepsis models, and YAP-pathway analysis, the work connects mouse PXR activation with gut–liver signaling rather than treating PCN as a purely hepatocyte-intrinsic intervention.
-
Atrial Natriuretic Peptide: Rat Research Workflows
2026-09-20
Build reproducible rat assays around Atrial Natriuretic Peptide for blood pressure, renal fluid balance, and adipose-metabolism studies. This workflow also shows how the adiponectin neuroinflammation study can inform experimental controls without overstating evidence for ANP.
-
WAY-100635: 5-HT1A Antagonist Guide
2026-09-19
WAY-100635 is a potent, selective, silent serotonin 5-HT1A receptor antagonist used in receptor binding, functional pharmacology, behavioral studies, and radioligand research. Its reported nanomolar activity supports serotonin receptor antagonist research, while assay-specific controls are required before extending results to pain or affective neuroscience.
-
Epoxomicin in ER Stress Assay Design
2026-09-18
Epoxomicin is a selective, irreversible proteasome inhibitor that can do more than suppress protein degradation. This article explains how to use it as a mechanistic probe for ER-associated degradation, N-degron signaling, assay interpretation, and disease-relevant proteostasis research.
-
Brassinolide Workflows for Plant and Cancer Assays
2026-09-18
Brassinolide supports distinct, decision-ready workflows for plant growth bioassays, PC-3 apoptosis studies, and exploratory diabetes research. This guide connects formulation, assay selection, structure–activity interpretation, and troubleshooting while separating published findings from practical optimization starting points.
-
EGF Migration Without EMT in A549 Cells
2026-09-17
The reference study shows that Epidermal Growth Factor stimulates A549 lung adenocarcinoma cell migration without producing a comparable epithelial–mesenchymal transition or invasive phenotype. Its side-by-side comparison with TGFβ separates motility from invasion and provides a useful framework for interpreting growth-factor responses in cancer cell models.
-
Dual-Color Viability Readouts for Translational Biology
2026-09-17
A mechanistic and strategic guide to using dual-fluorescent viability measurements in translational research, anchored in evidence from a dry-eye ferroptosis study and the APExBIO Live-Dead Cell Staining Kit K2081.
-
TBST: Assay Control from Wash to Readout
2026-09-16
TBST, or Tris-Buffered Saline and Tween 20, is more than a routine wash solution. This article explains how its detergent–buffer chemistry affects assay background, antibody selectivity, and the interpretation of uPAR–uPA cancer research, with practical guidance for reproducible Western blot, immunofluorescence, and immunohistochemistry workflows.
-
Atrial Natriuretic Peptide: Assay Design
2026-09-16
Explore how Atrial Natriuretic Peptide can support rigorous cardiovascular research, from natriuresis and blood pressure homeostasis to peptide identity and assay controls. This article also explains how an aged-rat adiponectin study informs, but does not establish, ANP neuroinflammation experiments.
-
BIIE 0246: Mapping NPY Y2R in Neural Assays
2026-09-15
BIIE 0246 is a selective neuropeptide Y Y2 receptor antagonist for separating presynaptic, feeding, and anxiety-related signaling. This article develops a receptor-attribution framework that connects established Y2R pharmacology with, but does not conflate it with, adipose-neural mechanisms implicated in cardiac arrhythmia.
-
VE-821: ATR Inhibition Across DDR and Viral Biology
2026-09-15
A translational perspective on VE-821 as a selective ATR kinase inhibitor, linking replication-stress biology, radiosensitization, chemotherapy sensitization, and emerging DNMT1-centered insights from human bocavirus research.